of neostigmine selectively stimulate the muscular activity of the intact human proximal colon and larger doses stimulate both the right and left colon. 1 These positive effects on healthy colon muscle followed the administration of subcutaneously administered neostigmine in doses as low as 0.75 mg. We commend the clinical investigators 2 who applied this physiology to the successful, noninvasive treatment of colonic pseudo-obstruction.
To the Editor--In rectal cancer situated below 5 cm from the anal verge, Rulleier and colleagues I evaluated the results of intersphincteric resection with excision of the internal anal sphincter and low coloanal anastomosis. Obviously our description of the same technique 2 went unnoticed by the authors.
In fact we have already described the procedure of intersphincteric resection of the rectum and anal canal in such cases. 2 It is worth mentioning that the puborectalis sling in addition to the medial edge of the levator plate should be sutured to the mobilized colon to achieve satisfactory continence. 
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Ultrasonic Dissection for Pseudomyxoma Peritonei: Debulking, Not Cytoreduction
To the Editor--We read with interest the article by Keating and Frizelle 1 regarding the use of the ultrasonic surgical aspirator in the treatment of pseudomyxoma peritonei. Our data and the experience reported by other groups show that the first requirement for optimal treatment of this disease is complete cytoreduction. This means that no viable tumor remains after the surgeon completes the dissection. This is technically and physically demanding for the surgeon. However, when combined with perioperative intraperitoneal chemotherapy it is a curative treatment in 85 percent of patients. In our opinion cytoreduction implies an attempt to remove tumors down to the cellular level, is always combined with intraperitoneal chemotherapy, and has curative intent. In contrast, debulking refers to an incomplete resection of malignancy, is rarely combined with intraperitoneal chemotherapy because of poor drug penetration into residual cancer nodules, and has palliative intent ( Fig. 1 ). By these definitions the ultrasonic surgical aspirator may have application in debulking but little or no use in an attempt at cytoreduction. Our group has, on several occasions, attempted to use ultrasonic dissection in combination with electrosurgery. We could see little or no advantage in the use of this tool over high-voltage, ball-tip electrosurgery. 2 In our opinion electroevaporative Vol. 43, No. 10 LETTERS TO THE EDITOR 1455 surgery remains the dissection tool of choice in the surgical treatment of pseudomyxoma peritonei.
There is a major problem with the use of the ultrasonic dissector to remove residual adherent mucinous tumor deposits after a greater and lesser omentectomy have been performed. In this setting ultrasonic dissection leaves a thin layer of viable tumor; it trims the tumor deposit down to the level of the surrounding tissues, but does not eliminate it completely. In contrast, electroevaporative surgery eliminates these deposits by a margin of heat necrosis on the treated surface. Cancer cells do not survive at the margin of an electrosurgical dissection2; the ultrasonic dissector leaves a margin of viable neoplastic tissue. We have witnessed the development of recurrent tumor masses on those surfaces previously treated with this device when these patients underwent reoperations.
Mucinous implants of pseudomyxoma peritonei adhere firmly to the underlying peritoneum; they can only be removed definitively by a localized peritoneal excision using peritonectomy procedures. 3 Occasionally one encounters mucinous tumor nodules on surfaces that cannot be peritonectomized. These tumor accumulations require a direct eradication. Most often this situation is encountered with mucinous tumor nodules on the small bowel. Isolated tumor nodules must be removed, because long portions of this viscus cannot be resected without detrimental nutritional consequences. This one situation could profit from skillful ultrasonic cytoreduction. All other surfaces, including the liver capsule, the undersurface of both hemidiaphragms, and the complete pelvic peritoneum are made disease-free by peritonectomy procedures and visceral resections.
Keating and Frizelle claimed improved access to all peritoneal surfaces by the ultrasonic dissection hand-piece. However, cytoreductive surgery requires adequate, wide exposure. We use a xyphopubic midline abdominal incision and a self-retaining retractor for this purpose. Direct visual access is available to all portions of the abdomen and pelvis using this approach.
As the authors acknowledge, ultrasonic dissection is slow and time-consuming. In our experience using high voltage electrosurgery, the time required to complete a potentially curative cytoreduction for pseudomyxoma peritonei is determined by the extent of the disease to be eliminated and its organ involvement. The time needed is 6 to 12 hours. Additional time devoted to the ultrasonic device is unwise unless its superiority has been established.
Peritoneal burn and consequently a prolonged ileus are given by the authors as a major disadvantage of electrosurgical dissection. We observe postoperative ileus after a complete cytoreduction in our patients, lasting approximately fourteen days. However, complete cytoreduction with long-term, disease-free survival in 85 percent of the patients is the result. The operative mortality is 2 percent and the Grade III and IV complications are 27 percent. 4 Although no phase III data are available, in our opinion the role of perioperative intraperitoneal chemotherapy in this setting cannot be sufficiently stressed. Its use after a complete cytoreduction and before anastomotic suture lines are constructed is a second absolute requirement of treatment. Our experience shows that both components are mandatory for an optimal management of this condition. 5, 6 Surgery alone may provide a few years of survival, given the slow, progressive nature of this disease. However, disease recurrence with intestinal obstruction, fistula formation, and ultimately death will always occur unless microscopic residual disease is eradicated. Extensive clinical data analysis from a 500-patient data base allows valid conclusions.< 7 Before ultrasonic dissection has shown benefit by long-term follow-up, the adequacy of this approach is suspect. The standard for treatment of pseudomyxoma peritonei is electrosurgical cytoreduction combined with perioperative intraperitoneal chemotherapy.
